NASDAQ:CMPX | Free Cash Flow | Compass Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2018-06-30 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$17.27M$82,000.00-$17.35M
2025-12-31-$13.25M$0.00-$13.25M
2025-03-31-$13.21M$18,000.00-$13.23M
2024-12-31-$9.16M$0.00-$9.16M
2024-03-31-$13.89M$0.00-$13.89M
2023-12-31-$12.35M$9,000.00-$12.36M
2023-03-31-$12.23M$0.00-$12.23M
2022-12-31-$10.64M$54,000.00-$10.7M
2022-03-31-$7.94M$194,000.00-$8.14M
2021-12-31-$4.67M$777,000.00-$5.44M
2021-03-31-$5.61M$128,000.00-$5.73M
2020-12-31-$6.57M$83,000.00-$6.66M
2020-03-31-$7.76M$12,000.00-$7.77M
2019-12-31-$5.59M$185,000.00-$5.78M
2019-03-31-$9,813.00
2018-06-30-$7,894.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$49.14M$25,000.00-$49.17M
2024-12-31-$44.86M$44,000.00-$44.9M
2023-12-31-$40.62M$30,000.00-$40.65M
2022-12-31-$34.13M$212,000.00-$34.34M
2021-12-31-$19.67M$1.57M-$21.23M
2020-12-31-$26.8M$106,000.00-$26.91M
2020-03-31-$32,106.00
2019-12-31-$31.74M$466,000.00-$32.21M
2019-03-31-$32,759.00